-
admin
Posts
Teva Delivers Strong Q2 Results and Raises Outlook for All Three Key Innovative Brands, Reflecting Continued Execution of Its Pivot to Growth Strategy
Q2 2026 revenues of $4.1 billion decreased by 1% in U.S. dollars year-over-year (YoY) and by 3% in local currency (LC) terms, mainly due to...
Hermès International: 2026 Half-year Results
Half-year information report as at the end of June 2026 Solid sales momentum and excellent results in the first halfRevenue amounted to €8.2 billion(+6% in...
BUREAU VERITAS – Delivering on our commitments with higher sequential organic growth in Q2 and continuous margin improvements
PRESS RELEASE Courbevoie, France – July 29, 2026 Delivering on our commitments with higher sequential organic growth in Q2 and continuous margin improvements H1...
Global Success, Local Intelligent Manufacturing – JAECOO 5 Set to Begin Local Production in South Africa
WUHU, China, July 28, 2026 (GLOBE NEWSWIRE) — Recently, OMODA & JAECOO officially broke ground on its first South African plant, with key model JAECOO...
Candel Therapeutics to Present at Canaccord Genuity’s 46th Annual Growth Conference in Boston
NEEDHAM, Mass., July 29, 2026 (GLOBE NEWSWIRE) — Candel Therapeutics, Inc. (Candel or the Company) (Nasdaq: CADL), a clinical-stage biopharmaceutical company focused on developing multimodal...
NewAmsterdam Pharma to Host Investor Day on August 5, 2026
NAARDEN, The Netherlands and MIAMI, July 29, 2026 (GLOBE NEWSWIRE) — NewAmsterdam Pharma Company N.V. (Nasdaq: NAMS or “NewAmsterdam” or the “Company”), a late-stage, clinical...
UroGen Pharma to Report Second Quarter 2026 Financial Results on Wednesday, August 5th, 2026
Conference Call and Webcast Scheduled for Wednesday, August 5th, 2026, at 10:00 AM ET PRINCETON, N.J., July 29, 2026 (GLOBE NEWSWIRE) — UroGen Pharma Ltd....
Noom Health partners with Levrx to bring personalized weight management support into the pharmacy benefits experience
PRINCETON, N.J., July 29, 2026 (GLOBE NEWSWIRE) — Noom Health, the enterprise arm of Noom and a leading behavior change platform, today announced a new...
Akebia Therapeutics to Report Second Quarter 2026 Financial Results and Discuss Recent Business Highlights
Akebia to Host Conference Call on August 5 at 4:30 p.m. EDT CAMBRIDGE, Mass., July 29, 2026 (GLOBE NEWSWIRE) — Akebia Therapeutics®, Inc. (Nasdaq: AKBA)...
Jushi Holdings Provides Update on Plan of Arrangement
BOCA RATON, Fla., July 29, 2026 (GLOBE NEWSWIRE) — Jushi Holdings Inc. (“Jushi” or the “Company”) (CSE: JUSH) (OTCQX: JUSHF), a vertically integrated, multi-state cannabis...
